Chenoweth DE , Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JWComplement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins . N Eng J Med1981; 304: 497-503.
2.
Kirklin JK, Westaby S., Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico ADComplement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg1983; 86: 847-57.
3.
Wildevuur Crh , van Oeveren W.Blood interactions in extracorporeal circulation: tests to evaluate the activation of proteins and formed blood elements. Life Supp Systems1987; 5: 85-91.
4.
Courtney JM, Sundaram S., Matata BM, Gaylor Jds.Biomaterials in cardiopulmonary bypass. Perfusion1994; 9: 3-10.
5.
Brash JLRole of plasma protein adsorption in the response of blood to foreign surfaces . In: Sharma CP, Szycher M (eds). Blood compatible materials and devices . Lancaster, PA: Technomics , 1991: 3-24.
6.
Kvarstein B. , Cappelen C., Osterud A.Blood platelets and leukocytes during cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg1974 ; 8: 142-45.
7.
van Oeveren W., Kazatchkine MD, Descamps-Latscha B. et al. Deleterious effects of cardiopulmonary bypass: a prospective study of bubble versus membrane oxygenation . J Thorac Cardiovasc Surg1985; 89: 888-99.
8.
Stahl RF, Fisher CA, Kucich U. et al. Effects of simulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity. J Thorac Cardiovasc Surg1991; 101: 230-39.
9.
Ryhaenen P., Herva E., Hollman A. et al. Changes in peripheral blood leucocyte counts, lymphocyte subpopulations, and in vitro transformation after heart valve replacement. J Thorac Cardiovasc Surg1979; 77: 259—66.
10.
Quiroga MM, Miyagishima R., Haendschen LC, Glovsky M., Martin BA, Hogg JCThe effect of body temperature on leukocyte kinetics during cardiopulmonary bypass. J Thorac Cardiovasc Surg1985; 90: 91-96.
11.
Pearl RG, Sladen RN, Rosenthal MHHaematologic effects of cardiac and noncardiac surgery. J Cardiothorac Anesth1987; 1: 205-209.
12.
Martin BA, Wright JL, Thommasen H., Hogg J.Effect of pulmonary blood flow on the exchange between the circulating and marginating pool of polymorphonuclear leukocytes in dog lungs. J Clin Invest1982; 69: 1277-85.
13.
Cavarocchi NC, Pluth JR, Schaff HV et al. Complement activation during cardiopulmonary bypass: comparison of bubble and membrane oxygenators . J Thorac Cardiovasc Surg1986; 91: 252-58.
14.
Butler J., Chong GL, Baigrie RJ, Pillai R., Westaby S., Rocker GMCytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation . Ann Thorac Surg1992; 53: 833-38.
15.
Royston D., Fleming JS, Desai JB, Westaby S., Taylor KMIncreased production of peroxidase products associated with cardiac operations: evidence for free radical generation. J Thorac Cardiovasc Surg1986; 91: 759-66.
16.
Zimmerman GA , Amory DWTranspulmonary polymorphonuclear leukocyte number after cardiopulmonary bypass. Am Rev Resp Dis1982; 126: 1097-98.
17.
Brigham KL, Meyrick B.Interactions of granulocytes with the lungs. Circ Res1984; 54: 623-35.
18.
Scleimer RP , Rutledge BKCultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin and tumour promoting phorbol esters. J Immunol1986; 136: 649-54.
19.
Watchfogel YT, Kucich U., Greenplate J. et al. Human neutrophil degranulation during extracorporeal circulation. Blood1987; 69: 324-30.
20.
Jochum M., Fritz H.Elastase and its inhibitors in intensive care medicine. Biomed Prog1990; 3: 55-59.
21.
Smedly LA, Tonnesen MG, Sandhaus RA et al. Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest1986; 77: 1233-43.
22.
Riegel W., Spillner G., Schlosser V., Horl WHPlasma levels of main granulocyte components during cardiopulmonary bypass . J Thorac Cardiovasc Surg1988; 95: 1014-19.
23.
Butler J., Parker D., Pillai R., Westaby S., Shale DJ, Rocker GMEffect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg1993; 105: 25-30.
24.
Weiss SJMechanisms of disease: tissue destruction by neutrophils. N Eng J Med1989; 20: 365-76.
25.
Cavarocchi NC, England MD, Schaff HVOxygen free radical generation during cardiopulmonary bypass: correlation with complement activation . Circulation1986; 74: 130-34.
26.
Heflin AC, Brigham KLPrevention by granulocyte depletion of increased vascular permeability in sheep following endotoxaemia. J Clin Invest1981; 68: 1253-60.
27.
Barrie PS, Tahamount MV, Mailk ABPrevention of increased pulmonary vascular permeability after pancreatitis by granulocyte depletion in sheep. Am Rev Resp Dis1982; 126: 904-908.
28.
Romson JL, Hook BG, Kumkel SL, Abrams GD, Schork MA, Lucchesi BRReduction of the extent of myocardial ischaemic injury by neutrophil depletion in the dog. Circulation1983; 67: 1016-23.
29.
Breda MA, Hall TS, Stuart RS et al. Twenty-four hour lung preservation by hypothermia and leukocyte depletion. Heart Transpl1985; IV: 325-29.
30.
Hall TS, Breda MA, Baumgartner WA et al. The role of leukocyte depletion in reducing injury to the lung after hypothermic ischaemia. Curr Surg1987 ; 44: 137-39.
31.
Pillai R., Bando K., Scheuler S., Zebley M., Reiz BA, Baumgartner WALeukocyte depletion results in excellent heart-lung function after 12 hours of storage. Ann Thorac Surg1990; 50: 211-14.
32.
Scheuler S., Hatanaka M., Bando K. et al. Twenty-four hour lung preservation with donor core-cooling and leukocyte depletion in a bilateral lung transplant model. Surgical Forum1990; 41: 405-407.
33.
Bando K., Scheuler S., Cameron DE et al. Twelve hour cardiopulmonary preservation using donor core-cooling, leukocyte depletion and liposomal superoxide dismutase. J Heart Lung Transplant1991; 10: 304-309.
34.
Breda MA, Drinkwater DC, Laks H. et al. Prevention of reperfusion injury in the neonatal heart with leukocyte depleted blood. J Thorac Cardiovasc Surg1989 ; 97: 654-65.
35.
Fukishima N. , Shirakura R., Nakata S. et al. Effects of terminal cardioplegia with leukocyte depleted blood on heart grafts preserved for 24 hours. J Heart Lung Transplant1992; 11: 676-82.
36.
Kawata H., Sawatari K., Mayer JEEvidence for the role of neutrophils in reperfusion injury after cold cardioplegic ischaemia in neonatal lambs. J Thorac Cardiovasc Surg1992; 103: 908-18.
37.
Bando K., Pillai R., Cameron DE et al. Leukocyte depletion ameliorates free-radical mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg1990; 99: 873-77.
38.
Byrne JG, Appleyard RF, Lee CC et al. Controlled reperfusion of the regionally ischaemic myocardium with leukocyte depleted blood. J Thorac Cardiovasc Surg1992; 103: 66-72.
39.
Gu YJ, Obster R., Gallandat Huet RCG, Eijgelaar A, van Oeveren W. Leukocyte depletion reduces the postoperative inflammatory response in patients following open heart surgery . Intensive Care Med199218: (suppl 2); S51.
40.
Pearl J., Drinkwater DC, Laks H., Caponoya ER, Gates RNLeukocyte-depleted preperfusion of transplanted human hearts. A randomised, double-blind clinical trial. J Heart Lung Transplant1992; 11: 1082-92.
41.
Chiba Y., Muraoka R., Haya AI, Morioka K., Sasaki M., Uesaka T.Leukocyte depletion and prevention of reperfusion injury during cardiopulmonary bypass: a clinical study. Cardiovasc Surg1993; 1: 350-56.
42.
Gourlay T., Fleming J., Taylor KMLaboratory evaluation of the Pall LG-6 leucocyte depleting arterial line filter . Perfusion1992; 7: 131-40.
43.
Gourlay T., Fleming J., Taylor KMThe effects of pulsatile flow on the leucocyte depleting qualities of the LG-6 leucocyte depleting arterial line filter. Perfusion1992; 7: 227-32.
44.
Thurlow PJ, Doolan L., Sharp R., Sullivan M., Smith B.Studies of the effect of Pall leucocyte filters LG6 and AV6 in an in vitro simulated extracorporeal circulatory system. Perfusion1995; 10: 291-300.
45.
Palanzo DA, Manley NJ, Montesano RM, Yiesley GL, Gordon D.Clinical evaluation of the Leuko Guard (LG6) arterial line filter for routine open heart surgery. Perfusion1993; 8: 489-96.
46.
Allen SM, Pagano D., Bonser RSPreliminary clinical evaluation of the Pall Leuko Guard (LG6) leucocyte depleting filter. Proc Scand AssocThorac Cardiovasc Surg1993; p. 86.
47.
Johnson D., Thompson D., Mycyk T., Burbridge B., Mayers I.Depletion of neutrophils by filtration during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status. Chest1995; 107: 1253-59.
48.
Palanzo DA, Manley NJCost effectiveness of using a leuko-depleting arterial line filter . Proc Am Acad Cardiovasc Perf1994; 15: 124-27.
Hachida M., Shimabukuro T., Okamura T. et al. The role of leucocyte depletion in reducing injury to the myocardium and lung during cardiopulmonary bypass. ASAIO J1995; 41: 291-95.
51.
Al-Ebrahim K., Shaffei H.Our experience with using the Pall LG6 leukocyte depleting filter during cardiopulmonary bypass. Ann Thorac Surg1993; 56: 1216-17.
52.
Mihaljevic T., Tonz M., von Segesser LK et al. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: a clinical study . J Thorac Cardiovasc Surg1995; 109: 1138-45.
53.
Weiss SJTissue destruction by neutrophils. New Eng J Med1989; 320: 365-76.
54.
Sawa Y., Matsuda H., Shimazaki Y. et al. Evaluation of leucocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg1994; 108: 1125-31.
55.
Pala MG, Paolini G., Paroni R. et al. Myocardial protection with and without leucocyte depletion: a comparative study on the oxidative stress. Proc Eur Assoc Cardiothorac Surg1994; p. 68.
Ichihara T. , Yasuura K., Maseki T. et al. The effects of using a leucocyte removal filter during cold blood cardioplegia. Jpn J Surg1994; 24: 966-72.
58.
Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W.Clinical performance of a high efficiency rapid flow leucocyte removal filter for leucocyte depletion of heparinised cardiopulmonary bypass perfusate . Perfusion1995; 10: 415-20.
59.
de Vries AJ, Gu YJ, Boonstra PW, van Oeveren W. Transfusion of leucocyte depleted heart-lung machine blood improves lung function following cardiopulmonary bypass. Proc EACTA 1995.